Opens in a new tab or window SAN FRANCISCO -- Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy (MDT) in addition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback